135 related articles for article (PubMed ID: 7668533)
1. Interleukin-6-type cytokines in myeloproliferative disease.
Hawley RG
Ann N Y Acad Sci; 1995 Jul; 762():294-307. PubMed ID: 7668533
[No Abstract] [Full Text] [Related]
2. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
3. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
[TBL] [Abstract][Full Text] [Related]
4. Regulation of oligodendrocyte cell survival and differentiation by ciliary neurotrophic factor, leukemia inhibitory factor, oncostatin M, and interleukin-6.
Vos JP; Gard AL; Pfeiffer SE
Perspect Dev Neurobiol; 1996; 4(1):39-52. PubMed ID: 9169918
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor and interleukin-11: cytokines with key roles in implantation.
Robb L; Dimitriadis E; Li R; Salamonsen LA
J Reprod Immunol; 2002; 57(1-2):129-41. PubMed ID: 12385838
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
7. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
8. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.
Selvakumaran M; Liebermann DA; Hoffman-Liebermann B
Mol Cell Biol; 1992 Jun; 12(6):2493-500. PubMed ID: 1588953
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology.
Álvarez N; Rodríguez-García A; Morales ML; Gutiérrez M; Montero M; Poza M; López N; Carreño G; Sánchez R; Cedena T; Rapado I; Martínez-López J; Ayala R
Leuk Res; 2021 Sep; 108():106613. PubMed ID: 34087683
[No Abstract] [Full Text] [Related]
10. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury.
Gadient RA; Patterson PH
Stem Cells; 1999; 17(3):127-37. PubMed ID: 10342555
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T
Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716
[TBL] [Abstract][Full Text] [Related]
12. The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL-6; next ONC, MGF, GCSF?
Patterson PH
Curr Opin Neurobiol; 1992 Feb; 2(1):94-7. PubMed ID: 1386269
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology.
Patterson PH
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7833-5. PubMed ID: 8058719
[No Abstract] [Full Text] [Related]
14. Upmodulation of alpha v beta 1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: correlation with increased cell adhesion on fibronectin.
Heymann D; Harb J; Ringeard S; Blanchard F; Lassort D; Raher S; Godard A
J Cell Biochem; 1995 Jul; 58(3):305-14. PubMed ID: 7593253
[TBL] [Abstract][Full Text] [Related]
15. [Leukemia inhibitory factor: a novel cytokine with multiple function].
Wang FS; Wu ZZ
Sheng Li Ke Xue Jin Zhan; 1993 Jan; 24(1):18-22. PubMed ID: 8332863
[No Abstract] [Full Text] [Related]
16. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
17. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
Tomida M
Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factors, cytokines and hematopoiesis.
Nakayama N; Hatake K; Miyajima A; Arai K; Yokota T
Curr Opin Immunol; 1989 Oct; 2(1):68-77. PubMed ID: 2514729
[No Abstract] [Full Text] [Related]
20. Antagonism of the IL-6 cytokine subfamily--a potential strategy for more effective therapy in rheumatoid arthritis.
Carroll G; Bell M; Wang H; Chapman H; Mills J
Inflamm Res; 1998 Jan; 47(1):1-7. PubMed ID: 9495579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
